Scilex Holding (SCLX) EBITDA Margin (2022 - 2026)
Scilex Holding (SCLX) posted quarterly EBITDA Margin of 374.06% for Q1 2026, up 18390.0% year-over-year from N/an in Q1 2025, and up 83.7% quarter-over-quarter from 2295.25% in Q4 2025.
Scilex Holding (SCLX) EBITDA Margin (2022 - 2026) Analysis & Trends
Scilex Holding's EBITDA Margin history runs 5 years deep, the most recent figure standing at 374.06% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 18390.0% year-over-year to 374.06%; the TTM figure through Mar 2026 stood at 1033.39% (down 85235.0% YoY), while the FY2025 annual figure was 1141.94%, down 99459.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 374.06%, up from 2295.25% in the prior quarter.
- The five-year high for EBITDA Margin was 93.31% in Q3 2022, with the low at 2295.25% in Q4 2025.
- The 5-year median for EBITDA Margin is 181.32% (2023), against an average of 428.13%.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin surged 24559 bps in 2024, then tumbled 210492 bps in 2025.
- Scilex Holding's EBITDA Margin stood at 165.63% in 2022, then rose by 18 bps to 136.23% in 2023, then slumped by 40 bps to 190.33% in 2024, then tumbled by 1106 bps to 2295.25% in 2025, then surged by 84 bps to 374.06% in 2026.
- Business Quant data shows SCLX's EBITDA Margin at 374.06% in Q1 2026, 2295.25% in Q4 2025, and 1766.21% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.13 Bn | 463.56 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 302.69 Bn | 295.00 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 236.53 Bn | 222.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 183.21 Bn | 180.03 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn | 28.37% |
| 9 | Gsk | 105.91 Bn | 101.75 Bn | 8.24 Bn | 5.72% |
| 10 | Scilex Holding | 39.90 Mn | -72.88 Mn | 3.97 Mn | -385.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -374.06% |
| Dec 31, 2025 | -2,295.25% |
| Sep 30, 2025 | -1,766.21% |
| Jun 30, 2025 | -207.23% |
| Mar 31, 2025 | -557.96% |
| Dec 31, 2024 | -190.33% |
| Sep 30, 2024 | -137.97% |
| Jun 30, 2024 | -95.44% |
| Mar 31, 2024 | -178.96% |
| Dec 31, 2023 | -136.23% |
| Sep 30, 2023 | -383.56% |
| Jun 30, 2023 | -181.32% |
| Mar 31, 2023 | -240.72% |
| Dec 31, 2022 | -165.63% |
| Sep 30, 2022 | -93.31% |
| Jun 30, 2022 | -144.73% |
| Mar 31, 2022 | -129.27% |